...
【24h】

Undertreatment of osteoporosis following hip fracture in the elderly.

机译:老年人髋部骨折后骨质疏松症的治疗不足。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The national Finnish guidelines for medical treatment of hip fracture patients are: osteoporosis medication and the daily concomitant use of vitamin D and calcium supplements. We investigated the post-fracture medical therapy for osteoporosis and the calcium and vitamin D therapy among hip fracture patients in two Finnish hospitals. The pre-fracture osteoporosis medication and use of calcium and vitamin D supplements of the patients were inquired on admission. The patient-specific use of osteoporosis medication and of prescribed calcium and vitamin D therapy during the follow-up time were checked from The Finnish Social Insurance Institution. At the end of the follow-up, those who were alive were inquired about the use of medication at the time. Eight percent of the 223 patients used osteoporosis medication and 8% used prescribed calcium and vitamin D supplements before the fracture. During the follow-up, the figures were 39% (52/133) and 53% (70/133), respectively, and at the end of the follow-up, correspondingly, 25% (29/114) and 44% (50/114). The follow-up time was 19.5-35 months. The post-fracture medical therapy for osteoporosis was insufficient. More effort should be focused on the secondary prevention following hip fracture in order to ensure the recommended treatment of osteoporosis.
机译:芬兰国家髋部骨折患者的医学治疗指南为:骨质疏松症药物以及每日并用维生素D和钙补充剂。我们在芬兰的两家医院中调查了髋骨骨折患者骨折后的骨质疏松药物治疗以及钙和维生素D疗法。入院时询问患者的骨折前骨质疏松症药物以及钙和维生素D补充剂的使用。随访期间,由芬兰社会保险机构检查了患者对骨质疏松症药物的特殊使用以及处方的钙和维生素D治疗方法。在随访结束时,还询问了那些还活着的人当时使用药物的情况。 223例患者中有8%在骨折前使用骨质疏松症药物,而8%则使用处方的钙和维生素D补充剂。在随访期间,数字分别为39%(52/133)和53%(70/133),在随访结束时分别为25%(29/114)和44%( 50/114)。随访时间为19.5-35个月。骨质疏松的骨折后药物治疗不足。为了确保对骨质疏松症的推荐治疗,应将更多的精力集中在髋部骨折后的二级预防上。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号